This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Launch-Pharma Technologies, Ltd.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Fayang Qiu: Innovator in Pharmaceutical Synthesis
Introduction
Fayang Qiu is a notable inventor based in Guangzhou, China. He has made significant contributions to the field of pharmaceutical synthesis, particularly in the development of methods for producing important medicinal compounds. His work is characterized by a focus on efficiency, purity, and environmental sustainability.
Latest Patents
Fayang Qiu holds a patent for an "Entecavir intermediate, synthetic method thereof and synthetic method for entecavir." This patent describes a synthetic method for entecavir that utilizes an intermediate, offering several advantages. The methods are controllable in chirality, high in yield and product purity, and utilize raw materials that are widely available and inexpensive. The reactions are simple, convenient to operate, and environmentally friendly, making them suitable for industrial-scale production.
Career Highlights
Fayang Qiu is currently employed at Launch-Pharma Technologies, Ltd., where he continues to innovate in the pharmaceutical sector. His expertise in synthetic methods has positioned him as a valuable asset in the development of new drugs and therapies.
Collaborations
Fayang has collaborated with several talented individuals in his field, including Fang Wang and Yehua Jin. These collaborations have further enhanced his research and development efforts, leading to advancements in pharmaceutical synthesis.
Conclusion
Fayang Qiu's contributions to the field of pharmaceutical synthesis are noteworthy, particularly his innovative methods for producing entecavir. His work exemplifies the intersection of science and practicality, paving the way for more efficient drug production.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile